<?xml version="1.0" encoding="UTF-8"?>
<ref id="B92-pharmaceuticals-13-00096">
 <label>92.</label>
 <element-citation publication-type="gov">
  <person-group person-group-type="author">
   <collab>Health Canada</collab>
  </person-group>
  <article-title>Important Safety Information on ACTEMRA
   <sup>®</sup> (tocilizumab)—Risk of Hepatotoxicity
  </article-title>
  <year>2019</year>
  <comment>Available online: 
   <ext-link ext-link-type="uri" xlink:href="https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/69991a-eng.php" xmlns:xlink="http://www.w3.org/1999/xlink">https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/69991a-eng.php</ext-link>
  </comment>
  <date-in-citation content-type="access-date" iso-8601-date="2020-04-20">(accessed on 20 April 2020)</date-in-citation>
 </element-citation>
</ref>
